Orchard Therapeutics (ORTX) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free ORTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Orchard Therapeutics Short Interest DataCurrent Short Volume31,500 sharesPrevious Short Volume27,200 sharesChange Vs. Previous Month+15.81%Dollar Volume Sold Short$517,860.00Short Interest Ratio / Days to Cover0.3Last Record DateJanuary 15, 2024Outstanding Shares22,760,000 sharesFloat Size22,370,000 sharesShort Percent of Float0.14%Today's Trading Volume0 sharesAverage Trading Volume157,287 sharesToday's Volume Vs. Average0% Short Selling Orchard Therapeutics ? Sign up to receive the latest short interest report for Orchard Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatORTX Short Interest Over TimeORTX Days to Cover Over TimeORTX Percentage of Float Shorted Over Time Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Orchard Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/202431,500 shares $517,860.00 +15.8%0.1%0.3 $16.44 12/31/202327,200 shares $447,440.00 -33.7%0.1%0.2 $16.45 12/15/202341,000 shares $672,810.00 +1.2%0.2%0.2 $16.41 11/30/202340,500 shares $656,505.00 -6.9%0.2%0.2 $16.21 11/15/202343,500 shares $696,435.00 +57.6%0.2%0.2 $16.01 10/31/202327,600 shares $439,116.00 -62.8%0.2%0.1 $15.91 Get the Latest News and Ratings for ORTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchard Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/202374,100 shares $1.18 million +67.7%0.4%0.3 $15.98 9/30/202344,200 shares $341,666.00 +116.7%0.2%0.2 $7.73 9/15/202320,400 shares $105,162.00 +126.7%0.1%0.5 $5.16 8/31/20239,000 shares $44,550.00 +20.0%0.1%0.4 $4.95 8/15/20237,500 shares $39,525.00 -14.8%0.0%0.3 $5.27 7/31/20238,800 shares $44,264.00 -59.8%0.1%0.2 $5.03 7/15/202321,900 shares $113,223.00 -74.6%0.1%0.5 $5.17 6/30/202386,200 shares $449,102.00 -14.0%0.5%1.9 $5.21 6/15/2023100,200 shares $496,992.00 +13.2%0.6%1.9 $4.96 5/31/202388,500 shares $424,800.00 +9.8%0.5%1.4 $4.80 5/15/202380,600 shares $433,628.00 -25.4%0.5%1.1 $5.38 4/30/2023108,100 shares $519,961.00 -1.2%0.6%1.7 $4.81 4/15/2023109,400 shares $548,641.00 -15.4%0.6%1.8 $5.02 3/31/2023129,300 shares $694,341.00 +46.9%0.8%2 $5.37 3/15/202388,000 shares $457,600.00 -91.9%0.7%0.8 $5.20 2/28/20231,080,000 shares $4.97 million +42.6%1.1%1 $4.60 2/15/2023757,600 shares $406,755.44 -4.8%0.7%0.8 $0.54 1/31/2023795,900 shares $442,997.94 +19.6%0.8%0.9 $0.56 1/15/2023665,500 shares $404,890.20 +38.5%0.6%0.8 $0.61 12/30/2022480,500 shares $178,265.50 -13.7%0.5%0.6 $0.37 12/15/2022556,800 shares $244,992.00 +67.5%0.5%1.7 $0.44 11/30/2022332,400 shares $147,020.52 +18.5%0.3%1.1 $0.44 11/15/2022280,600 shares $126,270.00 -9.8%0.2%0.9 $0.45 10/31/2022310,900 shares $140,588.98 +4.5%0.3%0.9 $0.45 10/15/2022297,400 shares $136,060.50 +9.5%0.3%0.6 $0.46 9/30/2022271,700 shares $135,850.00 -20.1%0.2%0.5 $0.50 9/15/2022340,200 shares $167,378.40 +17.4%0.3%0.5 $0.49 8/31/2022289,800 shares $150,753.96 +10.7%0.3%0.4 $0.52 8/15/2022261,800 shares $157,891.58 -63.9%0.2%0.3 $0.60 7/31/2022724,500 shares $383,985.00 -24.3%0.6%0.8 $0.53 7/15/2022957,500 shares $571,627.50 -29.6%0.8%1.1 $0.60 6/30/20221,360,000 shares $794,240.00 +2.3%1.2%1.7 $0.58 6/15/20221,330,000 shares $690,802.00 +61.5%1.1%1.9 $0.52 5/31/2022823,500 shares $374,692.50 +10.4%0.7%1.5 $0.46The #1 Investment of the Decade… (Ad)Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.To get all the details of this controversial tech – click here now. ORTX Short Interest - Frequently Asked Questions What is Orchard Therapeutics' current short interest? Short interest is the volume of Orchard Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 31,500 shares of ORTX short. 0.14% of Orchard Therapeutics' shares are currently sold short. Learn More on Orchard Therapeutics' current short interest. What is a good short interest percentage for Orchard Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.14% of Orchard Therapeutics' floating shares are currently sold short. Is Orchard Therapeutics' short interest increasing or decreasing? Orchard Therapeutics saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 31,500 shares, an increase of 15.8% from the previous total of 27,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Orchard Therapeutics' float size? Orchard Therapeutics currently has issued a total of 22,760,000 shares. Some of Orchard Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Orchard Therapeutics currently has a public float of 22,370,000 shares. How does Orchard Therapeutics' short interest compare to its competitors? 0.14% of Orchard Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Orchard Therapeutics: Anika Therapeutics, Inc. (5.64%), Aurora Cannabis Inc. (34.02%), Cerus Co. (3.09%), Organogenesis Holdings Inc. (12.55%), Solid Biosciences Inc. (3.01%), ModivCare Inc. (7.13%), LifeMD, Inc. (8.10%), Amarin Co. plc (3.94%), Aura Biosciences, Inc. (6.95%), Terns Pharmaceuticals, Inc. (10.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Orchard Therapeutics stock? Short selling ORTX is an investing strategy that aims to generate trading profit from Orchard Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orchard Therapeutics? A short squeeze for Orchard Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORTX, which in turn drives the price of the stock up even further. How often is Orchard Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORTX, twice per month. The most recent reporting period available is January, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Anika Therapeutics Short Squeeze Aurora Cannabis Short Squeeze Cerus Short Squeeze Organogenesis Short Squeeze Solid Biosciences Short Squeeze ModivCare Short Squeeze LifeMD Short Squeeze Amarin Short Squeeze Aura Biosciences Short Squeeze Terns Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORTX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge Alerts